Fractyl Health says experimental procedure helps maintain weight loss in study

Fractyl Health's stock surged 15% following the release of study data indicating that its investigational outpatient procedure may help maintain weight loss after patients discontinue GLP-1 receptor agonist medications. The company reported positive results suggesting the procedure could mitigate weight regain typically associated with ceasing GLP-1 drug therapy.